Corporate News     26-Dec-22
Alembic receives USFDA approval for Fulvestrant Injection
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per SingleDose Prefilled Syringe. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Faslodex Injection, 250 mg/5 mL (50 mg/mL), of AstraZeneca Pharmaceuticals LP. Fulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer.

Fulvestrant Injection, 250 mg/5 mL, has an estimated market size of US$71 million for twelve months ending Sep 2022 according to IQVIA.

Previous News
  Stock Alert: Alembic Pharma, Bajel Projects, Zydus Lifesciences, Lupin, Adani Enterprises, Biocon
 ( Market Commentary - Stock Alert 30-Sep-24   08:34 )
  Intellect Design Arena Ltd leads losers in 'A' group
 ( Hot Pursuit - 10-May-24   15:00 )
  Alembic Pharmaceuticals consolidated net profit rises 48.01% in the December 2023 quarter
 ( Results - Announcements 05-Feb-24   14:52 )
  Alembic Pharma gets USFDA nod for stroke and blood clots drug
 ( Hot Pursuit - 18-Jun-24   14:27 )
  Alembic Pharmaceuticals receives USFDA approval for Betamethasone Valerate Foam
 ( Corporate News - 24-Aug-24   14:03 )
  Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
 ( Corporate News - 18-Jun-24   18:52 )
  Alembic Pharma’s Gujarat unit gets EIR from USFDA
 ( Hot Pursuit - 28-Sep-24   13:02 )
  Alembic Pharma gets USFDA nod for Paliperidone extended-release Tablets
 ( Hot Pursuit - 27-Sep-24   13:40 )
  Alembic Pharma gets USFDA final approval for Prazosin Hydrochloride capsules
 ( Hot Pursuit - 08-Mar-23   09:19 )
  Volumes spurt at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 24-Apr-23   14:30 )
  Volumes soar at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 02-Jan-24   14:30 )
Other Stories
  Adani Ports records 14% growth in cargo volumes in September 2024
  03-Oct-24   09:37
  SignatureGlobal India launches new project in Gurugram
  03-Oct-24   09:34
  Biocon Biologics refinances debt through USD bonds and syndicated term loan
  03-Oct-24   09:29
  RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
  03-Oct-24   09:26
  Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
  03-Oct-24   09:23
  Transformers & Rectifiers India wins order of Rs 565 cr
  03-Oct-24   09:07
  Tata Motors records 12% decline in Q2 sales
  01-Oct-24   18:04
  Tata Motors records 15% decline in September sales
  01-Oct-24   17:55
  Man Infra set to launch its highly anticipated Vile Parle project
  01-Oct-24   17:48
  Padam Cotton Yarns to declare Quarterly Result
  01-Oct-24   17:39
Back Top